Skip to Content

Adastra Holdings Ltd Ordinary Shares XTRX

Morningstar Rating
CAD 0.21 +0.01 (5.13%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

XTRX is trading at a 52% discount.
Price
CAD 0.21
Fair Value
CAD 4.79
Uncertainty
Extreme
1-Star Price
CAD 4.62
5-Star Price
CAD 4.89
Economic Moat
Ftdw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if XTRX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
CAD 0.20
Day Range
CAD 0.210.21
52-Week Range
CAD 0.170.54
Bid/Ask
CAD 0.20 / CAD 0.24
Market Cap
CAD 11.47 Mil
Volume/Avg
3 / 10,444

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.51
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Adastra Holdings Ltd is an extraction and processing solutions company. It aims to develop and deploy large-scale cannabis and hemp extraction technologies and provide turnkey processing solutions to help licensed standard and micro-cultivators maximize the value of every harvest. The company has two operating segments comprised of manufacturing and non-manufacturing operations. The manufacturing operations include the manufacturing, sale, and distribution of cannabis-related products, and the non-manufacturing operations include PerceiveMD.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees

Valuation

Metric
XTRX
Price/Earnings (Normalized)
Price/Book Value
0.67
Price/Sales
0.51
Price/Cash Flow
12.32
Price/Earnings
XTRX

Financial Strength

Metric
XTRX
Quick Ratio
0.52
Current Ratio
0.87
Interest Coverage
−4.62
Quick Ratio
XTRX

Profitability

Metric
XTRX
Return on Assets (Normalized)
−6.53%
Return on Equity (Normalized)
−11.66%
Return on Invested Capital (Normalized)
−5.76%
Return on Assets
XTRX
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRKpstzmhzvXtstdg$70.9 Bil
ZTS
Zoetis Inc Class AXjnfxbdjLvqzc$68.9 Bil
HLN
Haleon PLC ADRLhprflcjDbhc$37.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRVfzxhcbhvKkqd$14.7 Bil
VTRS
Viatris IncTdvfzrkhvDjtl$13.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRNpsbhyrknLgwp$11.9 Bil
CTLT
Catalent IncNghdrsclPhjswhp$10.1 Bil
PRGO
Perrigo Co PLCQldkvqzvWwyq$4.1 Bil
CURLF
Curaleaf Holdings IncPbtzmlmsVgwnt$3.6 Bil
PBH
Prestige Consumer Healthcare IncSqzvqcvymDcvnctv$3.5 Bil

Sponsor Center